• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑块型银屑病伴/不伴代谢综合征患者血清对氧磷酶-1 活性和氧化状态。

Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome.

机构信息

Department of Medical Biochemistry, Ministry of Health Sivas Numune Hospital, Sivas, Turkey.

出版信息

J Clin Lab Anal. 2011;25(4):289-95. doi: 10.1002/jcla.20471.

DOI:10.1002/jcla.20471
PMID:21786331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6647565/
Abstract

OBJECTIVE

Psoriasis is a chronic immune-mediated inflammatory skin disease associated with metabolic syndrome, which is made up of a cluster of disorders, including obesity, diabetes mellitus, dyslipidemia, and cardiovascular disease. The aim of this study was to investigate serum paraoxonase-1 activities and oxidative status parameters in patients with plaque-type psoriasis with or without metabolic syndrome.

METHODS

In this study, patients with plaque-type psoriasis with (n=25) or without (n=27) metabolic syndrome, according to the criteria of the International Diabetes Federation (IDF), were matched for age and sex to an equally sized control group (n=25).

RESULTS

In patients without metabolic syndrome, serum paraoxonase and arylesterase activities showed mean decreases of 29 and 6%, respectively, whereas in patients with metabolic syndrome, the mean decreases in the enzymes' activities were 35 and 11%, respectively, compared with those in the control group. Serum total antioxidant capacity and total oxidant status were not statistically significant in any of the three groups. Multiple linear regression analysis revealed that HDL cholesterol and log-transformed triglyceride were independent variables for serum arylesterase activity and that fasting glucose and diastolic blood pressure were independent variables for serum paraoxonase activity.

CONCLUSIONS

These results suggest that according to the criteria of the IDF, the significant decrease observed in serum paraoxonase activity was independent of the metabolic syndrome in patients with mild-to-moderate plaque-type psoriasis, whereas the significant decrease in serum arylesterase activity was associated with the metabolic syndrome.

摘要

目的

银屑病是一种与代谢综合征相关的慢性免疫介导的炎症性皮肤病,代谢综合征由一系列疾病组成,包括肥胖症、糖尿病、血脂异常和心血管疾病。本研究旨在探讨斑块状银屑病患者伴或不伴代谢综合征时血清对氧磷酶-1 活性和氧化状态参数的变化。

方法

本研究中,根据国际糖尿病联合会(IDF)的标准,将 25 例伴代谢综合征的斑块状银屑病患者(观察组)和 27 例无代谢综合征的斑块状银屑病患者(对照组)按年龄和性别与 25 例年龄和性别相匹配的健康人(对照组)相匹配。

结果

在无代谢综合征的患者中,血清对氧磷酶和芳基酯酶活性分别平均下降 29%和 6%,而在有代谢综合征的患者中,与对照组相比,两种酶的活性分别平均下降 35%和 11%。三组患者的血清总抗氧化能力和总氧化状态均无统计学差异。多元线性回归分析显示,高密度脂蛋白胆固醇和对数转换的甘油三酯是血清芳基酯酶活性的独立变量,空腹血糖和舒张压是血清对氧磷酶活性的独立变量。

结论

根据 IDF 的标准,在轻中度斑块状银屑病患者中,观察到的血清对氧磷酶活性的显著下降与代谢综合征无关,而血清芳基酯酶活性的显著下降与代谢综合征有关。

相似文献

1
Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome.斑块型银屑病伴/不伴代谢综合征患者血清对氧磷酶-1 活性和氧化状态。
J Clin Lab Anal. 2011;25(4):289-95. doi: 10.1002/jcla.20471.
2
Serum lipid profile paraoxonase and arylesterase activities in psoriasis.银屑病患者的血清脂质谱、对氧磷酶和芳基酯酶活性
Cell Biochem Funct. 2009 Apr;27(3):176-80. doi: 10.1002/cbf.1553.
3
Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.慢性腺样体扁桃体炎患者的对氧磷酶和芳基酯酶活性以及总氧化/抗氧化状态
Int J Pediatr Otorhinolaryngol. 2011 Nov;75(11):1364-7. doi: 10.1016/j.ijporl.2011.07.017. Epub 2011 Sep 3.
4
Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.高密度脂蛋白相关对氧磷酶 1 活性与银屑病疾病中的全身炎症、疾病活动度和心血管危险因素的相关性。
Arthritis Rheumatol. 2018 Aug;70(8):1240-1250. doi: 10.1002/art.40499. Epub 2018 Jul 8.
5
Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.非糖尿病代谢综合征和肥胖不会影响血清对氧磷酶和芳基酯酶活性,但会影响氧化应激和炎症。
Eur J Endocrinol. 2010 Mar;162(3):535-41. doi: 10.1530/EJE-09-0732. Epub 2009 Dec 18.
6
Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.幽门螺杆菌感染受试者的血清对氧磷酶-1活性
Atherosclerosis. 2008 Jan;196(1):270-274. doi: 10.1016/j.atherosclerosis.2006.10.024. Epub 2006 Nov 27.
7
Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.心脏X综合征患者的对氧磷酶和芳基酯酶活性及其与氧化应激标志物的关系。
Coron Artery Dis. 2007 Mar;18(2):89-95. doi: 10.1097/MCA.0b013e32801104e8.
8
An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy: a cross-sectional study.难治性癫痫患儿血清对氧磷酶、芳基酯酶活性及氧化应激的评估:一项横断面研究
Epilepsy Res. 2014 Nov;108(9):1591-6. doi: 10.1016/j.eplepsyres.2014.08.007. Epub 2014 Sep 2.
9
Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.慢性乙型肝炎患者对氧磷酶活性与动脉粥样硬化的关联
Afr Health Sci. 2012 Jun;12(2):114-8. doi: 10.4314/ahs.v12i2.6.
10
Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy.腹腔镜胆囊切除术中总氧化剂状态、总抗氧化状态、对氧磷酶和芳基酯酶活性的变化。
Clinics (Sao Paulo). 2010 Mar;65(3):285-90. doi: 10.1590/S1807-59322010000300008.

引用本文的文献

1
Unraveling Mitochondrial Reactive Oxygen Species Involvement in Psoriasis: The Promise of Antioxidant Therapies.揭示线粒体活性氧在银屑病中的作用:抗氧化疗法的前景。
Antioxidants (Basel). 2024 Oct 11;13(10):1222. doi: 10.3390/antiox13101222.
2
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis-Preliminary Data.血清正五聚蛋白3和对氧磷酶1对银屑病患者发生心脏代谢紊乱的潜在预测价值——初步数据
Metabolites. 2022 Jun 22;12(7):580. doi: 10.3390/metabo12070580.
3
Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis.银屑病患者血清对氧磷酶-1(PON-1)酶的对氧磷酶和芳基酯酶活性:一项系统评价和荟萃分析
Clin Exp Med. 2023 Jun;23(2):301-311. doi: 10.1007/s10238-022-00818-z. Epub 2022 Mar 21.
4
The Involvement of Oxidative Stress in Psoriasis: A Systematic Review.氧化应激在银屑病中的作用:一项系统评价
Antioxidants (Basel). 2022 Jan 29;11(2):282. doi: 10.3390/antiox11020282.
5
High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions.过敏与皮肤病中的高密度脂蛋白(HDL):聚焦免疫调节功能
Biomedicines. 2020 Dec 1;8(12):558. doi: 10.3390/biomedicines8120558.
6
Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis.氧化应激是银屑病发病机制的重要因素。
Int J Mol Sci. 2020 Aug 27;21(17):6206. doi: 10.3390/ijms21176206.
7
Paraoxonase-1 and other factors related to oxidative stress in psoriasis.对氧磷酶-1与银屑病中氧化应激相关的其他因素
Postepy Dermatol Alergol. 2020 Feb;37(1):92-96. doi: 10.5114/ada.2020.93386. Epub 2020 Mar 9.
8
Effect on Adipose Tissue of Diabetic Mice Supplemented with n-3 Fatty Acids Extracted from Microalgae.补充源自微藻的 n-3 脂肪酸对糖尿病小鼠脂肪组织的影响。
Endocr Metab Immune Disord Drug Targets. 2020;20(5):728-735. doi: 10.2174/1871530320666200213111452.
9
Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic review and meta-analysis of case-control studies.银屑病患者血清脂质、脂蛋白和载脂蛋白水平的评估:病例对照研究的系统评价和荟萃分析
Postepy Dermatol Alergol. 2019 Dec;36(6):692-702. doi: 10.5114/ada.2019.91420. Epub 2019 Dec 30.
10
Investigation of oxidant and antioxidant levels in patients with psoriasis.探讨银屑病患者的氧化剂和抗氧化剂水平。
Turk J Med Sci. 2019 Aug 8;49(4):1085-1088. doi: 10.3906/sag-1807-257.

本文引用的文献

1
Serum lipid profile paraoxonase and arylesterase activities in psoriasis.银屑病患者的血清脂质谱、对氧磷酶和芳基酯酶活性
Cell Biochem Funct. 2009 Apr;27(3):176-80. doi: 10.1002/cbf.1553.
2
Psoriasis and the risk of incident diabetes mellitus: a population-based study.银屑病与新发糖尿病风险:一项基于人群的研究。
Br J Dermatol. 2008 Dec;159(6):1331-7. doi: 10.1111/j.1365-2133.2008.08814.x. Epub 2008 Sep 6.
3
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.动脉粥样硬化与银屑病中的炎症:共同致病机制及综合治疗方法的潜力
Br J Dermatol. 2008 Aug;159 Suppl 2:10-7. doi: 10.1111/j.1365-2133.2008.08780.x.
4
Psoriasis and metabolic disease: epidemiology and pathophysiology.银屑病与代谢性疾病:流行病学与病理生理学
Curr Opin Rheumatol. 2008 Jul;20(4):416-22. doi: 10.1097/BOR.0b013e3283031c99.
5
Association between psoriasis and the metabolic syndrome. A cross-sectional study.银屑病与代谢综合征之间的关联。一项横断面研究。
Dermatology. 2008;216(2):152-5. doi: 10.1159/000111512. Epub 2008 Jan 23.
6
Psoriasis and the metabolic syndrome.银屑病与代谢综合征。
Acta Derm Venereol. 2007;87(6):506-9. doi: 10.2340/00015555-0297.
7
Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations.皮肤疾病中氧化剂、抗氧化剂和细胞因子之间的相互作用:现状与未来考量
Biomed Pharmacother. 2007 Aug;61(7):412-22. doi: 10.1016/j.biopha.2007.05.010. Epub 2007 Jun 18.
8
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.银屑病患者代谢综合征的患病率:一项基于医院的病例对照研究。
Br J Dermatol. 2007 Jul;157(1):68-73. doi: 10.1111/j.1365-2133.2007.07986.x. Epub 2007 Jun 6.
9
The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.以色列银屑病、糖尿病与动脉粥样硬化之间的关联:一项病例对照研究。
J Am Acad Dermatol. 2007 Apr;56(4):629-34. doi: 10.1016/j.jaad.2006.09.017. Epub 2006 Dec 8.
10
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.中度至重度银屑病患者代谢综合征患病率增加。
Arch Dermatol Res. 2006 Dec;298(7):321-8. doi: 10.1007/s00403-006-0703-z. Epub 2006 Sep 22.